Dr Jalesh Panicker

Dr Jalesh PanickerTel: 020 3448 4713
Fax: 0203 448 4748
Email: jalesh.panicker@nhs.net

National Hospital for Neurology and Neurosurgery


Professional background

Dr Panicker is Consultant Neurologist in Uro-Neurology at the National Hospital for Neurology and Neurosurgery, and Honorary Senior Lecturer at the UCL Institute of Neurology, Queen Square, London.   He qualified in 1996 and subsequently trained in General Medicine and Neurology.  He became involved in the management of patients with neurogenic bladder dysfunction early in his career when running a neurorehabilitation service.   He has since developed and maintained an academic and clinical interest in Uro-Neurology. 

His primary interest is in understanding the neural control of the bladder and how it is affected in neurological disease.  Dr. Panicker works full time in the Department of Uro-Neurology and has a large clinical workload in this tertiary referral unit involved in the management of bladder and sexual dysfunction in patients with neurological diseases.    Most of the patients he sees in his Uro-neurology clinics have Multiple sclerosis, but he also has a particular interest in patients with Parkinson’s Disease, Cauda equina syndrome and unexplained urinary retention in young women, many of whom ultimately are found to have a primary disorder of sphincter relaxation (Fowler’s syndrome).  He often sees patients with unexplained bladder and sexual dysfunction referred for a neurological opinion.  He carries out pelvic neurophysiology, more often urethral or anal sphincter EMG.  Together with a urologist, uro-gynaecologist, gastroenterologist and nurses, the Uro-Neurology team provides a comprehensive approach for managing bladder, bowel and sexual dysfunction in patients with a variety of neurological disorders. 

He is involved in the training of medical students, junior doctors, nurses and MSc students and actively undertakes clinical research.  His publications include more than 65 articles in peer-reviewed journals and 15 book chapters.  In 2010, he co-edited a textbook “Pelvic Organ Dysfunction in Neurological Disease” together with Professor Clare Fowler and Dr Anton Emmanuel

Research interests

  • Understanding the neural control of the lower urinary tract
  • To improve continence in patients with neurogenic bladder dysfunction
  • Urinary retention and Fowler’s syndrome


Top 15 publications selected from 65 published papers

  1. Gamé X, Khan S, Panicker JN, Kalsi V, Dalton C, Elneil S, Hamid R, Dasgupta P, Fowler CJ. Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity.BJU International 2010 Oct 29. doi: 10.1111/j.1464-410X.2010.09791.x. [Epub ahead of print]
  2. Fowler CJ, Dalton C, Panicker JN.   Review of Neurologic Diseases for the Urologist; Urology Clinic of North America 2010; 37:517–526.
  3. Panicker JN, Fowler CJ. Uro-Neurology.  Practical Neurology 2010;10:178-85.
  4. Wuethrich PY, Kessler TM, Panicker JN, Curatolo M, Burkhard FC. Detrusor Activity Is Impaired during Thoracic Epidural Analgesia after Open Renal Surgery. Anesthesiology. 2010 May 10. [Epub ahead of print]
  5. Panicker JN, de Sèze M, Fowler CJ.  Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management.Clinical Rehabilitation 2010;24:579-89.
  6. Gamé X, Fowler CJ, Panicker JN.  Neuropathic bladder dysfunction. Trends in Urology, Gynaecology & Sexual Health2010;15;23-28.
  7. Panicker JN, Haslam C.  Lower urinary tract dysfunction in Multiple Sclerosis: Management options in a community setting.  British Journal of Community Nursing 2009; 14(11) 474-480.
  8. Kessler TM, Khan S, Panicker JN, Elneil S, Brandner S, Fowler CJ, Roosen A. In the Human Urothelium and Suburothelium, IntradetrusorBotulinum Neurotoxin Type A Does Not Induce Apoptosis: Preliminary Results.European Urology 2009 Sep 11. [Epub ahead of print].
  9. Panicker JN, Nagaraja D, Kovoor JM, Nair KP, Subbakrishna DK. Lower urinary tract dysfunction in acute disseminated encephalomyelitis.Multiple Sclerosis 2009;15(9):1118-1122.
  10. Panicker JN, Menon L, Anandkumar A, Sundaram KR, Fowler CJ. Lower urinary tract symptoms following neurological illness may be influenced by multiple factors: Observations from a neurorehabilitation service in a developing country.Neurourology and Urodynamics 2009 May 27. [Epub ahead of print].
  11. Khan S, Panicker J, Roosen A, Gonzales G, Elneil S, Dasgupta P, Fowler CJ, Kessler TM. Complete Continence after Botulinum Neurotoxin Type A Injections for Refractory Idiopathic Detrusor Overactivity Incontinence: Patient-Reported Outcome at 4 Weeks.European Urology 2009 Apr 21. [Epub ahead of print].
  12. Kessler TM, Khan S, Panicker J, Roosen A, Elneil S, Fowler CJ. Clean intermittent self-catheterization after botulinum neurotoxin type A injections: short-term effect on quality of life.Obstetrics &Gynecology 2009;113(5):1046-1051.
  13. Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SC, Kirby M, Lucas M, Macleod N, Mangnall J, North A, Porter B, Reid S, Russell N, Watkiss K, Wells M. A UK consensus on the management of the bladder in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry2009;80(5):470-477.
  14. Kessler TM, Fowler CJ, Panicker JN. Sexual dysfunction in multiple sclerosis.Expert Reviews of Neurotherapeutics 2009;9(3):341-350.
  15. Roosen A, Datta SN, Chowdhury RA, Patel PM, Kalsi V, Elneil S, Dasgupta P, Kessler TM, Khan S, Panicker J, Fry CH, Brandner S, Fowler CJ, Apostolidis A. Suburothelialmyofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.European Urology 2009;55(6):1440-1448.

GMC/GDC number: 6164983